Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. (NVCT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NVCT · as of Jun 9, 2026
Key Statistics
Explore Nuvectis Pharma, Inc. Data
nvct stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The NVCT analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +6.16% upside from the current price of $9.42.
Competitors & Peers
nvct competitorsNVCT
ARMP
CGEN
CRDF
CYBN
IPHAStock Performance
Full HistoryAbout Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative…
what is nuvectis pharma, inc. · nvct stock overview · nuvectis pharma, inc. company profile · who is nuvectis pharma, inc. ceo · nvct NASDAQ · nuvectis pharma, inc. headquarters · nuvectis pharma, inc. business segments
About Stock Overview & Key Data
Nuvectis Pharma, Inc. (NVCT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 4, 2022. As of the latest trading session, NVCT stock price is $9.42, with a market capitalization of $249.9M. The stock has returned +6.44% over the past 12 months and +24.77% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Nuvectis Pharma, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2025, Nuvectis Pharma, Inc. reported revenue of — and net income of -$26.4M. For detailed data — including Nuvectis Pharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Nuvectis Pharma, Inc. (NVCT) stock price is $9.42. The stock is traded on NASDAQ under the ticker symbol NVCT. The 52-week range is $5.55 – $13.34.